HBV Viral Load and Liver Enzyme Levels May Be Associated with the Wild MBL2 AA Genotype

Table 1

Clinical, biochemical, and histopathological data according to the Metavir scores of the study population.

Variables	HBV		HCV
	AC	IC
Sex
Male (%)	22 (55.0%)	19 (76.0%)	50 (54.4%)
Female (%)	18 (45.0%)	06 (24.0%)	42 (45.6%)
Mean age (years ± SD)
Male	51.90 ± 14.20	52.58 ± 15.49	53.60 ± 11.18
Female	42.90 ± 13.49	42.66 ± 06.88	54.29 ± 08.34
Liver enzymes
ALT (UI/L) Mean ± SD; (08–54 UI/L)	67.20 ± 62.34	27.10 ± 12.27	77.64 ± 59.27
AST (UI/L) Mean ± SD; (16–40 UI/L)	67.05 ± 72.48	26.88 ± 10.13	65.35 ± 39.27
GGT (UI/L) Mean ± SD; (08–63 UI/L)	56.69 ± 92.12	58.75 ± 80.98	96.87 ± 90.76
Fibrosis scores
F 0 to 2 (%)	17 (51.5)	07 (100.0)	36 (59.0%)
F 3 to 4 (%)	16 (48.5)	00 (00.0)	25 (41.0%)
Inflammatory activity
A 0 to 1 (%)	16 (80.0)	07 (100.0)	42 (59.2%)
A 2 to 3 (%)	04 (20.0)	00 (00.0)	29 (40.8%)

HBV: hepatitis B virus (AC: active carrier; IC: inactive carrier) and HCV: hepatitis C virus. ALT: alanine aminotransferase; AST: aspartate aminotransferase; and GGT: gamma-glutamyl transferase. Fibrosis score (0 to 2: mild and moderate and 3 to 4: severe and cirrhosis) Metavir. Degree of inflammation (0 to 1: mild inflammation and 2 to 3: severe inflammation).